Alan Bradley
Founder at Kymab Group Ltd.
Alan Bradley active positions
Companies | Position | Start | End |
---|---|---|---|
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | Director/Board Member | - | - |
Independent Dir/Board Member | - | - | |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Chief Tech/Sci/R&D Officer | - | - |
Founder | - | - | |
University of Cambridge | Corporate Officer/Principal | - | - |
Career history of Alan Bradley
Former positions of Alan Bradley
Companies | Position | Start | End |
---|---|---|---|
ExpressionEdits Ltd. | Founder | - | - |
Baylor College of Medicine | Corporate Officer/Principal | - | - |
LEXICON PHARMACEUTICALS, INC. | Founder | - | - |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - | - |
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Founder | 31/01/2000 | - |
Training of Alan Bradley
University of Cambridge | Doctorate Degree |
Statistics
International
United Kingdom | 5 |
United States | 4 |
Cayman Islands | 2 |
Operational
Founder | 5 |
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Private companies | 5 |
---|---|
Spectral Genomics, Inc.
Spectral Genomics, Inc. BiotechnologyHealth Technology Spectral Genomics is a biotechnology company that makes DNA microarrays and chips which can be used in cloning and genome profiling. Its arrays are made from bacterial artificial chromosomes (BACs). The company's Spectral Chip and Constitutional Chip are designed to highlight the genome's spots in research. The company supplies BAC clones to university laboratories and biotech and pharmaceutical research and development facilities. Spectral Genomics also sells the SpectralWare Array Analysis System, software designed for use in conjunction with the company's arrays. Spectral Genomics is headquartered in Houston, TX | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Health Technology |
Sieger Healthcare Acquisition Corp.
Sieger Healthcare Acquisition Corp. Financial ConglomeratesFinance Sieger Healthcare Acquisition Corp. is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company was founded on May 18, 2021, and is headquartered in Singapore. | Finance |
ExpressionEdits Ltd. | Commercial Services |
- Stock Market
- Insiders
- Alan Bradley
- Experience